News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
776,808 Results
Type
Article (78959)
Company Profile (394)
Press Release (697455)
Section
Business (211984)
Career Advice (3326)
Deals (38044)
Drug Delivery (118)
Drug Development (87750)
Employer Resources (174)
FDA (17629)
Job Trends (16502)
News (368198)
Policy (37607)
Tag
Academia (2963)
Alliances (53699)
Alzheimer's disease (1370)
Approvals (17563)
Artificial intelligence (169)
Bankruptcy (368)
Best Places to Work (12380)
Biotechnology (257)
Breast cancer (201)
Cancer (1474)
Cardiovascular disease (126)
Career advice (2813)
CAR-T (111)
Cell therapy (320)
Clinical research (69651)
Collaboration (528)
Compensation (272)
COVID-19 (2806)
C-suite (122)
Data (1433)
Diabetes (195)
Diagnostics (6645)
Earnings (79977)
Employer resources (153)
Events (118481)
Executive appointments (416)
FDA (18353)
Funding (459)
Gene therapy (221)
GLP-1 (717)
Government (4957)
Healthcare (20503)
Infectious disease (2909)
Inflammatory bowel disease (126)
Interviews (627)
IPO (17313)
Job creations (4578)
Job search strategy (2351)
Layoffs (491)
Legal (9193)
Lung cancer (219)
Manufacturing (236)
Medical device (14377)
Medtech (14382)
Mergers & acquisitions (20899)
Metabolic disorders (534)
Neuroscience (1731)
NextGen Class of 2024 (7320)
Non-profit (5012)
Northern California (1743)
Obesity (303)
Opinion (244)
Patents (130)
People (62691)
Phase I (21475)
Phase II (30345)
Phase III (22821)
Pipeline (531)
Postmarket research (3300)
Preclinical (9648)
Radiopharmaceuticals (258)
Rare diseases (296)
Real estate (6931)
Regulatory (25065)
Research institute (2631)
Resumes & cover letters (516)
Southern California (1508)
Startups (3992)
United States (16036)
Vaccines (664)
Weight loss (236)
Date
Today (2)
Last 7 days (263)
Last 30 days (2260)
Last 365 days (37340)
2024 (37269)
2023 (42188)
2022 (53538)
2021 (58312)
2020 (57234)
2019 (50616)
2018 (38527)
2017 (36047)
2016 (36509)
2015 (42421)
2014 (36465)
2013 (32592)
2012 (34380)
2011 (34473)
2010 (34036)
Location
Africa (1117)
Arizona (209)
Asia (46219)
Australia (8079)
California (3963)
Canada (1473)
China (325)
Colorado (185)
Connecticut (197)
Europe (106418)
Florida (555)
Georgia (146)
Illinois (449)
Indiana (240)
Maryland (678)
Massachusetts (3114)
Michigan (193)
Minnesota (313)
New Jersey (1162)
New York (1124)
North Carolina (859)
Northern California (1743)
Ohio (150)
Pennsylvania (946)
South America (1492)
Southern California (1508)
Texas (579)
Utah (116)
Washington State (415)
776,808 Results for "u s army medical research institute of infectious diseases usamriid".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
Smith+Nephew, the global medical technology company, announced they have entered into a Master Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research.
February 28, 2024
·
5 min read
Business
RedHill and U.S. Army Announce Opaganib’s Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that novel, twice daily, oral opaganib[1], delivered a statistically significant increase in survival time when given at 150 mg/kg twice a day (BID) in a United States Army Medical Research Institute of Infectious Diseases (USAMRIID) in vivo Ebola virus study, making it the first host-directed molecule to show activity in Ebola virus disease.
October 3, 2023
·
13 min read
Pharm Country
Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
Virpax Pharmaceuticals Announces Preliminary Results of Probudur TM Pilot Study with the U.S. Army Institute of Surgical Research.
February 7, 2024
·
6 min read
Press Releases
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024
·
6 min read
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
BioMidwest
RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Receive $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics
RION, a leading clinical-stage regenerative medicine company, announced that it will collaborate with Mayo Clinic and the U.S. Army Medical Research Institute for Chemical Defense on a $2.4M grant awarded from the Department of Defense.
November 20, 2023
·
3 min read
Press Releases
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
November 13, 2024
·
3 min read
Shionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats
Shionogi & Co., Ltd. announced the company is responding to the urgent global need for additional antimicrobial research and development by establishing its first discovery laboratory in the U.S., in San Diego, California.
June 3, 2024
·
9 min read
Business
Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
Virpax ® Pharmaceuticals, Inc. today announced that the cooperative research and development agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) to evaluate Virpax’s Probudur™, an injectable long-acting liposomal bupivacaine formulation that is injected at the wound site, has been extended to September of 2024.
October 12, 2023
·
5 min read
Bio NC
Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19
Inhalon Biopharma announced that it has been awarded a $5.7 million contract by the U.S Army Medical Research and Development Command to support a U.S. Army Military Performance Advancement Initiative project to develop new treatments for COVID-19 and other SARS infections.
November 15, 2023
·
4 min read
1 of 77,681
Next
